The Drug sector has been on the SIA watch list for several months as a relative strength gainer. As such, today we will highlight a drug name in the Favored Zone of the SIA S&P 500 Index report. AbbVie Inc (ABBV), with a market capitalization of $383B, currently sits in the 100th out of 505 spots in SIA S&P 500 Index Report, up 141 spots in the last quarter and is up 10.28% over this trailing quarter and 19.34% over the past 6 months.